Overview

The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients

Status:
Unknown status
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to explore and identify the effects of acetylcysteine, a common mucolytic with anti-oxidant property, on alleviating the damage caused by increased oxidative stress in hemodialysis patients.
Phase:
Phase 4
Details
Lead Sponsor:
Far Eastern Memorial Hospital
Treatments:
Acetylcysteine
N-monoacetylcystine